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Abstract
Background: Streptococcus suis is a zoonotic pathogen that infects pigs and can occasionally cause serious infections in
humans. S. suis infections occur sporadically in human Europe and North America, but a recent major outbreak has been
described in China with high levels of mortality. The mechanisms of S. suis pathogenesis in humans and pigs are poorly
understood.
Methodology/Principal Findings: The sequencing of whole genomes of S. suis isolates provides opportunities to
investigate the genetic basis of infection. Here we describe whole genome sequences of three S. suis strains from the same
lineage: one from European pigs, and two from human cases from China and Vietnam. Comparative genomic analysis was
used to investigate the variability of these strains. S. suis is phylogenetically distinct from other Streptococcus species for
which genome sequences are currently available. Accordingly, ,40% of the ,2 Mb genome is unique in comparison to
other Streptococcus species. Finer genomic comparisons within the species showed a high level of sequence conservation;
virtually all of the genome is common to the S. suis strains. The only exceptions are three,90 kb regions, present in the two
isolates from humans, composed of integrative conjugative elements and transposons. Carried in these regions are coding
sequences associated with drug resistance. In addition, small-scale sequence variation has generated pseudogenes in
putative virulence and colonization factors.
Conclusions/Significance: The genomic inventories of genetically related S. suis strains, isolated from distinct hosts and
diseases, exhibit high levels of conservation. However, the genomes provide evidence that horizontal gene transfer has
contributed to the evolution of drug resistance.
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Introduction
Streptococcus suis is a Gram positive coccus that colonises pigs.
While it is generally carried asymptomatically in adult pigs, it can
cause severe systemic disease in piglets, manifested as a rapidly
fatal sepsis associated with meningitis, polyarthritis and pneumo-
nia. Why adult pigs carry the causative bacteria asymptomatically
while piglets develop acute disease is unknown. The main site of
carriage in the adult are the tonsils, but bacteria have also been
isolated from the nasal cavities, the gastrointestinal tract and
genital tract. The carriage rate in adult pigs can approach 100%
and this organism has been a worldwide problem for the pig
industry for a number of years. S. suis has also been isolated from a
range of other mammalian and avian species [1].
S. suis is an important zoonotic agent. The first case in humans
was described in Denmark in 1968 [2]. Human infection with S.
suis occurs sporadically in Europe and North-America and case
reports suggest that it is almost exclusively related to occupational
exposure to pigs or pork products. Incidences of human infection
with S. suis are greater in S.E. Asia and China. Meningitis is the
most common presentation in humans, but septicaemia and
endocarditis are also seen. In areas of Vietnam, S. suis is the main
cause of acute bacterial meningitis in adults [3] and it is the third
most common cause of meningitis in Hong Kong. The incidence
of S. suis infection in humans is almost certainly under-reported.
Most cases have been described as being caused by serotype 2
isolates, but other serotypes can cause human disease [4].
Recently two outbreaks of severe acute disease in humans with
high morbidity and mortality in humans have been reported in
China [5], in both cases due to serotype 2 strains. An outbreak in
1998 killed 14 of 25 patients, and an outbreak in 2005 affected 204
people, killing 38 of them (19%), a mortality rate around two to
four times that previously reported. A high proportion of people in
these outbreaks had a toxic shock-like syndrome, and most of the
deaths occurred in this group rather than in those suffering
meningitis. Streptococcal toxic shock syndrome (STSS) was
previously associated with Streptococcus pyogenes, so the emergence
of STSS due to presumptive zoonotic S. suis infection is of
considerable concern [6]. One isolate from each of these outbreaks
has been sequenced [7] and this has identified a proposed
pathogenicity island (PI) that may be involved in this particular
clinical manifestation of S. suis infection, although this remains
speculative at this stage. The PI was identified through comparison
of the Chinese strains to the unfinished, unannotated genome
sequence of strain P1/7 from the Sanger Institute. In this paper we
present the completed fully annotated genome sequence of strain
P1/7. In addition we have sequenced the genomes of two other S.
suis strains, SC84 and BM407, which are human isolates from
China and Vietnam respectively. Strain SC84 is a representative
of the of 2005 outbreak in China [8].
Materials and Methods
Bacterial strains, growth and DNA isolation
S. suis strain P1/7 was isolated from an ante-mortem blood
culture from a pig dying with meningitis [9], and is ST1 by MLST
[10]. S. suis strain BM407 is also ST1, and was isolated from CSF
from a human case of meningitis in Ho Chi Minh City, Vietnam
in 2004 [3]. S. suis strain SC84 is ST7, which is closely related to
ST1, and was isolated from a case of streptococcal toxic shock-like
syndrome in Sichuan Province, China in 2005 [8]. Strain P1/7 is
resistant to gentamycin, streptomycin, neomycin, nalidixic acid,
and sulfamethoxazole, and sensitive to penicillin, ampicillin,
cephalotin, erythromycin, tulathromycin, clarythromycin, linco-
mycin, clindamycin, pirlimicin, tetracycline, trimethoprim-sulfa,
ciprofloxacin, and chloramphenicol. Strain BM407 is resistant to
trimethoprim-sulfamethoxazole, tetracycline, erythromycin, azith-
romycin and chloramphenicol and susceptible to penicillin,
ceftriaxone and vancomycin. Strain SC84 is resistant to tetracy-
cline, and susceptible to penicillin, ampicillin, cefotaxime,
ceftriaxone, cefepime, meropenem, levofloxacin, chloramphenicol,
erythromycin, azithromycin, clindamycin, and vancomycin [11].
Bacteria were cultured in Todd-Hewitt-broth at 37uC for 18 h
and pelleted at 10,0006g. The cells were resuspended in 30 ml of
lysis solution (10 mM NaCl, 20 mM Tris HCl pH 8, 1 mM
EDTA, 0.5% SDS) and incubated at 50uC overnight. Three ml of
5 M sodium perchlorate was added and incubated for 1 h at
ambient temperature. After phenol chloroform extraction the
DNA was precipitated with ethanol, spooled into deionised water
and stored at 220uC. DNA was also extracted using a genomic
DNA extraction kit (G-500, Qiagen).
Whole genome sequencing
The genome of S. suis strain P1/7 was sequenced to
approximately 8-fold coverage, from pUC18 (insert size 2.8–
3.3 kb), and pMAQ1b_SmaI (insert size 3.0–3.3 kb) genomic
shotgun libraries using big-dye terminator chemistry on ABI3730
automated sequencers. End sequences from large insert BAC
libraries in pBACehr (insert size 10–25 kb) and pBACe3.6 (insert
size 12–15 kb) were used as a scaffold. All repeat regions were
bridged by read-pairs or end-sequenced polymerase chain reaction
(PCR) products.
S. suis SC84 and BM407 genomes were sequenced using
multiple sequencing technologies to generate contiguous drafts.
The bulk of the sequencing for both projects was generated using
454/Roche GS20 and Solexa sequencing platforms. The 454
sequencing of strain SC84 generated 399,145 reads with an
average length of 102.7 bp, which assembled de novo into 281 non-
redundant contigs using the 454/Roche Newbler assembly
program. The 454 sequencing of strain BM407 generated
223,282 reads with an average length of 103.1 bp, which
assembled de novo into 1939 non-redundant contigs. The Solexa
sequencing of strain SC84 generated 32,016,513 reads with a
length of 37 bp, and of strain BM407 generated 1,769,043 reads
with a length of 37 bp which were each assembled by alignment to
a reference (strain P1/7) sequence using the ssaha2 [12] alignment
program. Data from the 2 technologies, were merged to produce
39 non-redundant contigs in SC84, and 390 non-redundant
contigs in BM407.
The merging process involved using the random in silico
sheering of the 454 de novo assembly consensus contigs to create
500 bp consensus reads with 250 bp overlaps. This generated a
fasta tiling path representing each of the 454 de novo assembly
contigs. These were then assembled together with all the capillary
shotgun reads using phrap2gap [13] to merge the two technologies
The contigs were reordered based on BLAST [14] alignments
with strain P1/7. The gaps between these contigs were closed by
directed PCR and the products sequenced with big dye terminator
chemistry on ABI3730 capillary sequencers. Aligned Solexa
sequencing was merged to confirm assembly and also confirm
sequence in 454 only regions. For the SC84 project capillary
coverage was 56, 454 coverage was 196and Solexa coverage was
1906, and for the BM407 project capillary coverage was 56, 454
coverage was 116 and Solexa coverage was 206.
The sequences and annotations of the Streptococcus suis P1/7,
SC84 and BM407 genomes have been deposited in the EMBL
database under accession numbers AM946016, FM252031, and
FM252032 and FM252033 respectively.
Streptococcus suis Genomics
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The sequence was annotated using Artemis software [15]. Initial
coding sequence (CDS) predictions were performed using
Orpheus [16], Glimmer2 [17], and EasyGene [18] software.
These predictions were amalgamated, and codon usage, positional
base preference methods and comparisons to the non redundant
protein databases using BLAST [14] and FASTA [19] software
were used to refine the predictions. The entire DNA sequence was
also compared in all six potential reading frames against UniProt,
using BLASTX [14] to identify any possible coding sequences
previously missed. Protein motifs were identified using Pfam [20]
and Prosite [21], transmembrane domains were identified with
TMHMM [22], and signal sequences were identified with SignalP
version 2.0 [23]. rRNAs were identified using BLASTN [14]
alignment to defined rRNAs from the EMBL nucleotide database;
tRNAs were identified using tRNAscan-SE [24]; stable RNAs
were identified using Rfam [25].
Comparative genomics
Comparison of the genome sequences was facilitated by using
the Artemis Comparison Tool (ACT) [26] which enabled the
visualization of BLASTN and TBLASTX comparisons [14]
between the genomes. Orthologous proteins were identified as
reciprocal best matches using FASTA [19] with subsequent
manual curation. Pseudogenes had one or more mutations that
would prevent correct translation; each of the inactivating
mutations was subsequently checked against the original sequenc-
ing data. Small scale variation including: SNPs and insertions and
deletions, were identified by using the SNP detection pipeline of
MUMmer [27]. Clonalframe v1.1 was used to identify regions of
the S. suis chromosomes associated with recombination [28].
Streptococcus sequences used for comparative genomic analysis
were: S. suis 05ZYH33 (accession number CP000407) [7], S. suis
98HAH33 (accession number CP000408) [7], S. pyogenes Manfredo
(accession number AM295007) [29], Streptococcus equi 4047
(accession number FM204883) [30], Streptococcus uberis 0140J
(accession number AM946015) [31], Streptococcus thermophilus
CNRZ1066 (accession number CP000024) [32], Streptococcus
pneumoniae TIGR4 (accession number AE005672) [33], Streptococcus
sanguinis SK36 (accession number CP000387) [34], Streptococcus
mutans UA159 (accession number AE014133) [35], Streptococcus
agalactiae NEM316 (accession number AL732656) [36], and
Streptococcus gordonii str. Challis substr. CH1 (accession number
CP000725) [37]. The sequences were also compared wth
Lactococcus lactis subsp. lactis IL1403 (accession number
AE005176) [38].
Phylogenetic analysis
Sequences alignment were made using R-coffee [39] and the
alignments inspected and edited using Seaview (v4.0) [40].
Bayesian analysis was performed using Mr Bayes [41,42]. The
model of sequence evolution used was the generalized time-
reversible (GTR) model with gamma-distributed rate variation.
The analysis was run with 26105 generations, and the first 56104
were discarded as burn-in. The tree drawn with FigTree (v1.2.2;
http://tree.bio.ed.ac.uk/software/figtree/).
Results
The genome of S. suis strain P1/7, a pig disease isolate
The genome of Streptococcus suis P1/7 consists of a single circular
chromosome of 2,007,491 bp (Figure 1; accession number
AM946016) containing 1,908 predicted protein coding sequences
(CDSs; Table 1), 82 of which are pseudogenes or gene fragments
(Table S1). S. suis is phylogenetically distinct among the
streptococci for which genome sequences are available (Figure 2).
Pairwise genomic comparisons reveal very little conservation of
gene order with other species (data not shown). Orthologue
comparisons against all of the other available streptococcal
genomes identified that approximately 60% of the P1/7 genome
is orthologous to CDSs in the genomes of other Streptococcus species
(Table 2). The highest number of orthologous matches was
identified in S. sanguinis (66.1%), followed by S. gordonii (65.6%).
Analysis of the functions of the P1/7 orthologues present in
other streptococcal species identified that some functional groups
are more widely conserved than others (Figure 3), and that some
exhibit a wide range of distribution across the species compared.
Many of the core housekeeping functions such as fatty acid
metabolism, chaperones, macromolecule biosynthesis, and nucle-
otide biosynthesis exhibit the highest conservation. For these
classes, .85% of the CDSs of these classes have orthologous
matches in all the other streptococci compared. In some cases, for
example ribosomal proteins, a lower level of orthologous matches
in a strain is due to differences in gene prediction, rather than the
absence of a CDS per se. In contrast, some functional groups such
as cofactor biosynthesis and amino acid biosynthesis exhibit a
lower level of conservation and probably reflect the available
nutrients in the niches occupied by the individual streptococcal
species. Many of the more variably distributed orthologous
functional groups are associated with the acquisition and uptake
of nutrients, for example macromolecule and small molecule
degradation, as well as responses to environmental stresses and
stimuli.
Excluding CDSs in mobile genetic elements (MGE), 283 CDSs
(14.9%) in the P1/7 genome do not have orthologous matches
(have been) in any of the other Streptococcus species (Table S2).
These have been designated S. suis orphans and include: a
transporter cluster (SSU0039 to SSU0044), a putative endopep-
tidase (SSU0152), a glucosamine-6-phosphate isomerase
(SSU0206), a putative lipase (SSU0304), a putative deoxyguano-
sinetriphosphate triphosphohydrolase (SSU0327), capsule associ-
ated CDSs (SSU0520 to SSU0529), a UDP-galactopyranose
mutase (SSU0563), a MATE family transporter (SSU0573), EPS
associated CDSs (SSU1115, SSU1125 and SSU1128), a putative
oligopeptidase (SSU1679), and a putative choline binding protein
(SSU1911) (Table S2).
Virulence genes in the P1/7 genome
The mechanisms by which S. suis cause disease in humans and
pigs are poorly understood. Many putative virulence functions
have been identified, however no single function is crucial for the
pathogenesis of S. suis. Many putative virulence genes are only
present, or expressed, in some S. suis isolates, suggesting that
combinations of virulence factors may be more important than
individual functions. Additionally, several of the functions may be
important for colonization and carriage, rather than disease.
Analysis of the S. suis genomes reveals an array of CDSs encoding
potentially important functions.
Polysaccharides and capsule. Like most other pathogens
that can cause meningitis, S. suis expresses a polysaccharide
capsule. P1/7 is serotype 2 and contains a locus (SSU0515 to
SSU0529) for the biosynthesis of type 2 capsule [43,44]. The
structure of the S. suis serotype 2 capsule is unknown, but it is
composed of glucose, galactose, N-acetylglucosamine, rhamnose
and sialic acid in a ratio of 1:3:1:1:1 [45]. Although 35 serotypes of
S. suis have been described, type 2 is most frequently associated
with disease in pigs and humans [3,46–48]. Capsule plays a role in
the virulence of S. suis; type 2 capsule mutants are avirulent in
murine and pig models of infections [43,49] The capsule itself can
Streptococcus suis Genomics
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mediate prostaglandin E2 (PGE2) and matrix metalloproteinase 9
(MMP-9) production by human macrophages [50] suggesting a
role in pathogenesis of disease.
The P1/7 genome also contains a cluster of genes that appears
to encode the components required for the biosynthesis of a
putative exopolysaccharide (SSU1111 to SSU1133; Figure S1a).
Included in this are CDSs encoding enzymes for synthesis of the
exopolysaccharide building blocks, for processing and for export.
Analysis of the cluster suggests that it is involved in the synthesis of
a rhamnose-glucose-like polysaccharide (RGP), and is similar to
components of RGP biosynthesis identified in S. mutans (Figure
S1b). Four loci have been identified in S. mutans that encode
proteins necessary for RGP synthesis: RmlA, RmlC, RmlB, and
RmlD direct the synthesis of dTDP-L-rhamnose from D-glucose-
Figure 1. Schematic circular diagram of the S. suis P1/7 genome. Key for the circular diagram (outer to inner): scale (in Mb); annotated CDSs
coloured according to predicted function are shown on a pair of concentric circles, representing both coding strands; Streptococcus suis orphan CDSs,
purple; orthologue matches shared with the Streptococcal species, S. mutans UA159, S. gordonii Challis CH1, S. sanguinis SK36, S. pyogenes Manfredo,
S. equi 4047, S. agalactiae NEM316, S. uberis 0140J, S. pneumoniae TIGR4, S. thermophilus CNRZ1066, blue; orthologue matches shared with
Lactococcus lactis subsp. lactis, green; G+C% content plot; G+C deviation plot (.0% olive, ,0% purple). Colour coding for P1/7 CDS functions: dark
blue, pathogenicity/adaptation; black, energy metabolism; red, information transfer; dark green, surface associated; cyan, degradation of large
molecules; magenta, degradation of small molecules; yellow, central/intermediary metabolism; pale green, unknown; pale blue, regulators; orange,
conserved hypothetical; brown, pseudogenes; pink, phage and IS elements; grey, miscellaneous.
doi:10.1371/journal.pone.0006072.g001
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1-phosphate [51,52]; GluA produces UDP-D-glucose [53], RgpG
initiates RGP synthesis by transfer of N-acetylglucosamine-1-
phosphate to a lipid carrier [54], and proteins from an operon
encoding six proteins (rgpABCDEFHI) are required for the
transport and assembly of the rhamnan repeat unit backbone,
and glucose side chain formation [55,56].
The putative exopolysaccharide biosynthetic cluster between
CDSs SSU1111 and SSU1133, contains homologues of rmlACB
and rmlD (SSU1129, SSU1130, SSU1132 and SSU1133), and
rgpABCD and F (SSU1124, SSU1123, SSU1122, SSU1121 and
SSU1120) (Figure S1a). The two clusters of rml and rgp
homologues are separated by four CDSs encoding a putative
sulphatase (SSU1125), a mannosyl-glycoprotein endo-beta-N-
acetylglucosaminidase gene fragment (SSU1126), a putative N-
acetylmuramoyl-L-alanine amidase (SSU1127), and a surface-
anchored protein containing an LPXTS motif (SSU1128). In
addition to the homologues of the S. mutans rpg genes, there is also a
flippase (SSU1119), and six glycosyl transferases (SSU1117,
SSU1116, SSU1115, SSU1114, SSU1113 and SSU1111). Homo-
logues of gluA (SSU1828) and rgpG (SSU1672) are located at two
other loci on the P1/7 genome. Unlike the S. mutans RGP cluster,
the P1/7 cluster does not contain homologues of rmlE, rmlH and
rmlI. These genes encode proteins that are involved in glucose side
chain formation [56], therefore it is likely that the polysaccharide
produced by P1/7 has a different repeat unit structure to that
produced by S. mutans.
The cluster does not appear to encode an obvious repeat unit
polymerase. Downstream of the flippase is a membrane protein
(SSU1118) that has weak similarity matches to proteins of
unknown function. Due to the sequence diversity of repeat unit
polymerases, it is not always possible to annotate them by
sequence similarity. Hydrophobicity plot profile comparison has
been used to identify tentatively these polymerases [57]. A
comparison of the hydrophobicity plot of SSU1118 with those of
known polymerases identified a similar profile (data not shown).
RGPs constitute serospecific-antigens that form the basis of
some streptococcal serotyping. These molecules are associated
with modulating host immune cell interactions, and may have a
role in eliciting sepsis. Streptococcal RGPs stimulate human
monocytes in vivo to release inflammatory cytokines, including
tumor necrosis factor alpha and interleukin-1b [58], induce NO
synthase activity [59], and confer resistance to phagocytosis by
human polymorphonuclear leukocytes [60]. Elevated NO pro-
duction has been observed in animal models of bacterial
meningitis and also in human patients with the disease [61,62].
In a mouse model of S. suis infection, high levels of inflammatory
cytokines were observed both systemically and in the central
nervous system [63]. Distinct from the type 2 capsule, it is possible
that the exopolysaccharide encoded by this cluster may have an
important role in virulence and may contribute to the inflamma-
tory response during S. suis infection.
Protein secretion and secreted proteins. In the publication
by Chen et al. describing the genomes of two Chinese S. suis isolates
[7], they presented possible virulence-associated factors or pathways
in S. suis, including strain P1/7. This analysis identified thirteen
components of a Type II secretion system and one component of a
Type III secretion system in the genome of strain P1/7. Our
analysis of the genome failed to identify components of either
secretion system, although components of Sec and SRP pathways
were identified. Neither Type II, nor Type III secretion systems
have been identified in Gram-positive bacteria, and it is therefore
very unlikely that S. suis secretes proteins via these pathways. It
would appear that the description of these secretion system
components in S. suis is a case of mistaken identity due to sub-
optimal transitive annotation. The S. suis genome contains CDSs
that have weak similarity to components of these Gram-negative
protein secretion systems, but these genes in S. suis encode proteins
that are involved in the transport of other molecules, or are
components of functionally distinct systems. The observed similarity
owes more to distant evolutionary relationships rather than
conservation of function [64].
Suilysin (SSU1231) is a secreted thiol-activated cytolysin [65]
produced by some strains of S. suis [66]. This protein is part of a
family of cytolysins that play a role in disease caused by several
bacterial pathogens [67]. The role that suilysin plays in S. suis
disease is unclear. Immunization of pigs with suilysin provided
partial protection from S. suis infection [68]. However, while a
suilysin mutant was avirulent in a mouse infection model, it was
only slightly attenuated in a model of infection in pigs [69].
Surface proteins. Several of the previously characterized S.
suis virulence factors are cell wall-anchored proteins. These
sortase-processed proteins contain a C-terminal LPXTG-type
processing motif. The genome of strain P1/7 contains a large
number (28) of proteins of this type: all but five contained C-
terminal LPXTG motifs followed by non-polar and basic amino
acid motifs. The other five putative surface proteins (SSU1128,
SSU1885, SSU1186, SSU1888 and SSU1889) contained LPXTS,
IPXTG, IPXTG, YPXTG and LYXTG motifs respectively.
Previous studies have identified five sortase homologues in S. suis
(srtA-E) by PCR screening with degenerate primers [70]. An
additional sortase CDS was identified (SSU0428) in the P1/7
genome [71].
In addition, the S. suis P/7 genome contains a protein
(SSU0879) with an atypical N-terminal LPXTG-type motif. This
protein is similar to the large surface zinc metalloproteinases of S.
pneumoniae; 39.9% identical to the zinc metalloprotease precursor
ZmpC [72], 33.7% identical to Immunoglobulin A (IgA)1 protease
precursor Iga [73], and 28.3% identical to the zinc metallopro-
tease precursor ZmpB [74]. In S. pneumoniae these proteins interact
directly with the host immune system, and play an inferred role in
virulence. ZmpC mutants in S. pneumoniae led to reduced mortality
in an experimental mouse model of intranasal challenge and sepsis
[72]. ZmpC cleaves human matrix metalloproteinase 9 (MMP-9),
Table 1. General properties of the genomes of S. suis strains
P1/7, SC84 and BM407.
P1/7 SC84 BM407
Size (bp) 2,007,491 2,095,898 2,146,229
G+C content 41.3% 41.1% 41.1%
CDSs 1908 1985 2040
Coding % 85.1% 84.8% 83.9%
Av. gene length (bp) 931 933 932
rRNA (16S-23S-5S) 4 4 4
tRNA 56 56 56
miscellaneous RNA 13 13 13
Pseudogenes and partial
genes
82 87 108
IS elements 27 28 32
Genomic islands 4 4 3
ICE regions 0 1 2
Plasmid - - 1*
doi:10.1371/journal.pone.0006072.t001
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thought to lead to the proteolytic activation of this matrix
remodelling protein [72]. Matrix metalloproteinases can contrib-
ute to blood–brain barrier (BBB) disruption during bacterial
meningitis [75,76]. MMP-9 produced by leukocytes during
meningitis is essential to enable them to migrate through the
BBB. A consequence of the increase in the permeability of the
BBB mediated by MMP-9, is that bacterial cells are able to
migrate to the central nervous system and cause further tissue
damage. S. suis capsule induces MMP-9 production in macro-
phages in an in vivo model [50]: it is possible that the S. suis zinc
metalloproteinase may also play a role in increasing MMP-9
activity.
IgA1 protease mediates the site-specific cleavage of human IgA1
in the hinge region [73]. IgA is the major class of immunoglobulin
in mucosal secretions of the upper respiratory tract, and functions
by interfering with microbial attachment to host tissues. The
activity of IgA1 protease may help pathogens to subvert the
antigen specificity of the humoral immune response, and facilitate
adhesion and persistence at the mucosal surface [77].
Analysis of extracellular proteins produced by S. suis identified
two proteins, muramidase-released protein (MRP) [78] and
extracellular protein factor (EF) [79], associated with disease and
mortality in pigs (MRP+, EF+) [79]. Variation in the expression of
these proteins has been observed in S. suis isolates. Although MRP
and EF were originally identified as markers of disease, most S. suis
serotype 2 strains isolated from diseased pigs in Canada are
phenotypically negative for MRP and EF [80]. Additionally,
mutation of both proteins had no measurable effect on
pathogenicity [81]. P1/7 is phenotypically positive for MRP and
EF (MRP+, EF+). In the genome of P1/7, EF appears to be
encoded in the first ORF of a larger mutated CDS (SSU0171).
The entire CDS encodes a putative surface-anchored protein, and
is split into three reading frames by a frameshift and nonsense
mutations; the 5-prime reading frame encoding EF, contains an N-
Figure 2. Phylogenetic relationships of S. suis to the other genome sequenced streptococci. Unrooted majority-rule tree of Bayesian
analysis of combined 16S rRNA and RNase P RNA gene datasets. The was tree built from 16S rRNA and rnpB gene sequences from the genomes of the
Streptococcus species: S. suis P1/7, S. mutans UA159, S. gordonii Challis CH1, S. sanguinis SK36, S. pyogenes Manfredo, S. equi 4047, S. agalactiae
NEM316, S. uberis 0140J, S. pneumoniae TIGR4, and S. thermophilus CNRZ1066. Lactococcus lactis subsp. lactis IL1403 was included as an outgroup. The
numbers at the branches are posterior probabilities indicating the support for the branch. The bar indicates the number of substitutions per site (4
per 100 sites).
doi:10.1371/journal.pone.0006072.g002
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terminal signal sequence, and the 3-prime reading frame contains
a LPXTG sortase-processing motif. The EF+ phenotype of P1/7 is
probably due to the expression of the 5-prime reading frame.
Unlike MRF and EF, opacity factor (OFS) is a large surface-
associated protein that may play a role in the virulence of S. suis
[82]. The N-terminus of OFS is homologous to the N-terminal
regions of the fibronectin-binding protein A (FnBA) of Streptococcus
dysgalactiae and the serum opacity factor of S. pyogenes. Mutational
studies have suggested a role for OFS in virulence, but not
colonization. However in strain P1/7 OFS (SSU1474) is mutated,
containing two frameshift mutations.
Two of the LPXTG proteins were found in a cluster similar to
the pilus islands identified in S. agalactiae [83], and comprise the
main pilus subunit (SSU0427) and ancillary subunit of this pilus
(SSU0425). In addition the cluster contains a signal peptidase
(SSU0424) and a sortase (SSU0428). The genome contains a
second pilus cluster, containing 3 sortases, srtD, srtC, srtB
(SSU1881, SSU1882, SSU1883), ancillary protein 1 (SSU1885),
the main pilus subunit (SSU1886), ancillary protein 2 (SSU1888)
and ancillary protein 3 (SSU1889). In silico analysis of the P1/7
genome suggests that this strain does not express complete pili, as
both of the clusters contain pseudogenes; SSU0425 contains a
nonsense mutation, and SSU1886 and SSU1888 contain frame-
shift mutations. To this end it is worth noting that orthologous
CDS in the other sequenced S. suis strains are also pseudogenes.
The genome also contains an incomplete pilus cluster that contains
a signal peptidase (SSU0450) and sortase SrtE (SSU0453), but
lacks pilus subunits and ancillary subunits. Between the signal
peptidase and sortase there are a putative exported protein
(SSU0451) and a transposase fragment (SSU0452). It is possible
that the putative exported protein represents the N-terminal
region of a pilus protein that has been truncated by a deletion
event that generated the partial transposase sequence. Evidence
for the potential role of pili in S. suis pathogenesis has come from in
Figure 3. Functional distribution of Streptococcal orthologues in the S. suis P1/7 genome. Functional groups are displayed clockwise on
the web graph, in decreasing range of orthologue matches for a single category.
doi:10.1371/journal.pone.0006072.g003
Table 2. Orthologues of S. suis P1/7 CDSs in other
streptococci.
% of CDSs with
orthologous matches
S. sanguinis SK36 66.1
S. gordonii CH1 65.6
S. agalactiae nem316 64.4
S. agalactiae 2603v 64.0
S. agalactiae A909 63.6
S. uberis 0140J 63.9
S. pneumoniae D39 64.2
S. pneumoniae TIGR4 63.8
S. pneumoniae R6 63.6
S. mutans UA159 61.2
S. equi 4047 60.1
S. pyogenes Manfredo 57.9
S. thermophilus CNRZ1066 55.6
S. thermophilus LMG 18311 55.1
Orthologues matches are displayed as a percentage of the total CDSs in the P1/
7 genome.
doi:10.1371/journal.pone.0006072.t002
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vitro work looking for preferentially expressed genes in S. suis upon
interaction with porcine brain microvascular endothelial cells [71].
The signal peptidase (SSU0424) of the S. agalactiae-like cluster is
upregulated, as is srtE, the sortase belonging to the incomplete
pilus cluster.
Comparison of cell wall-anchored proteins among streptococcal
species shows that they are one of the most variable components of
the genome; 13 out of the 29 proteins in P1/7 were unique to S.
suis (Table S2), the rest being intermittently distributed. Interest-
ingly, orthologues of several of the S. suis cell wall-anchored
proteins, or proteins associated with their processing, were
conserved within the meningitis-associated streptococci (Table 2).
Six of the cell wall-anchored proteins, and four of the sortases were
found in S. agalactiae and/or S. pneumoniae, and were absent in other
streptococci [84].
In addition to LPXTG-type cell wall-anchored proteins, the
P1/7 genome also contains other surface-exposed proteins that
may play an important role in modulating host-cell interactions.
The P1/7 genome encodes a protein, SSU0496, which contains a
Mac 1 domain (PF09028), an N-terminal signal sequence and a C-
terminal transmembrane domain. The Mac 1 domain is found in a
small number of streptococcal proteins that modulate the immune
response. Mac, also known as IdeS, is a cysteine protease secreted
by S. pyogenes [85,86]. Two allelic families of Mac have been
identified in S. pyogenes; Mac I and Mac II [87] exhibit sequence
divergence in the middle third of the proteins (,50% amino acid
identity in this region). Mac was originally named because it had
limited sequence homology to the a-subunit of the leukocyte b2
integrin, Mac-1 [85]. S. pyogenes Mac proteins block polymorpho-
nuclear leukocyte opsonophagocytosis and inhibit the production
of reactive oxygen species [87]. The mechanisms of action of the S.
pyogenes Mac allelic families differ; Mac I binds to, and cleaves, the
hinge region of human IgG [88] whereas Mac-2 exhibits lower
levels of endopeptidase activity, and does not bind IgG, but instead
to the IgG receptor, Fcc [89]. Homologues of Mac have been
identified in Streptococcus equi subsp. equi (349 amino acids), the
causative agent of strangles, and the related pathogen Streptococcus
equi subsp. zooepidemicus [90]. In S. equi the Mac homologue is
expressed during infection, and reduces the antiphagocytic activity
of equine neutrophils [91].
SSU0496 is similar (,29% sequence identity) in the N-terminal
region to the S. pyogenes Mac I and II proteins. In comparison, the
S. suis protein is considerably larger than the S. pyogenes Mac
proteins, comprising 1141 amino acids as opposed to ,340 amino
acids. The enzymatic activities of S. pyogenes Mac proteins have
been characterized, and they belong to a novel family of cysteine
proteases [88]. Protein alignment of the S. suis protein with the S.
pyogenes proteins shows that the amino acids of the catalytic triad
(Cys94, His262 and Asp284) are conserved. The S. suis protein
however, is missing an Arg-Gly-Asp (RGD) integrin-binding motif
present in the other streptococcal proteins, suggesting that while it
may possess the peptidase activity of its homologues it may lack the
ability to bind integrin.
Comparative genomics of streptococci that can cause
meningitis
Several species of Streptococcus have been associated with
meningitis in humans: S. pneumoniae is an important cause of
bacterial meningitis [92], and S. agalactiae is important in this
regard [93]. Comparative genomic analysis was used to identify
components of the S. suis genome shared with S. pneumoniae and S.
agalactiae that were absent in other streptococci. Three strains of S.
agalactiae, NEM316 [94], 2603V/R [95] and A909 [96] and three
strains of S. pneumoniae, R6 [97], TIGR4 [33] and D39 [98], have
been sequenced thus far. Whilst S. pneumoniae strain TIGR4 is from
a case of invasive disease, and S. agalactiae strains NEM316,
2603V/R and A909 are all clinical isolates, none of the strains
appears to come from a meningitis case. 71 CDSs were identified
that were present in at least one of the strains of S. pneumoniae or S.
agalactiae, but were absent in other Streptococcus species (Table 3). Of
these 12 were found in MGEs in the P1/7 genome. The
distribution of orthologue matches is varied between species and
between strains; only 5 CDSs (SSU0685, SSU0686, SSU0687,
SSU1050 and SSU1403) have orthologue matches in all of the
strains for both species. Amongst these common CDSs are 3 CDS
that form part of an operon and encode a phosphomethylpyr-
imidine kinase, a hydroxyethylthiazole kinase and a thiamine-
phosphate pyrophosphorylase. These 3 CDSs catalyse the final
steps in the biosynthesis of thiamine monophosphate from
pyrimidine and thiazole molecules. The other CDSs in this
operon, SSU0684, encodes a putative phosphatase which does not
have any orthologue matches. Another of the CDSs common to S.
suis, S. agalactiae and S. pneumoniae encodes a PadR family
regulatory protein
The final common CDS encodes a hyaluronidase. Hyaluron-
idase has been described as a virulence factor of S. pneumoniae; the
addition of hyaluronidase to an intra-nasal inoculum was
necessary to cause invasive disease in an infant mouse model of
meningitis [99]. Hyaluronidase mutants do not appear to be
attenuated in a murine model of meningitis after intracerebral
infection [100], suggesting that this degradative enzyme may be
important for the bacteria to cross the mucosa or the BBB during
the early stages of pathogenesis. Notably in all five S. suis strains
sequenced, including the human meningitis strains this CDS is
present as a pseudogene. A study investigating the distribution of
hyaluronidases in a diverse collection of S. suis isolates identified
fewer than 30% exhibited hyaluronate lyase activity in vitro,
although all the isolates tested (n. 309) contained the hyaluronidase
gene (hly) [101]. In many cases mutations were identified that
disrupted the expression of hly. Notably hyaluronate lyase activity
was absent in the majority of isolates associated with invasive
disease (meningitis and septicaemia), whereas activity was detected
more often in isolates associated with pneumonia.
Given the unknown potential to cause meningitis of the S.
agalactiae and S. pneumoniae strains sequenced, variably distributed
matches should not be ruled out as having important roles in
causing meningitis. Some of these CDSs encode functions that are
important for pathogenesis, such as the zinc metalloproteinase
previously mentioned. Orthologues of this protein are present in
all of the S. pneumoniae strains compared but absent in S. agalactiae
(Table 3). Components of the two pilus clusters are amongst the
differentially distributed matches.
Comparative genomics of two geographically distinct
human disease strains SC84 and BM407
S. suis strain SC84 is a human isolate, and was isolated from the
same outbreak as Chinese S. suis strain 05ZYH33 [8]. Strains from
this outbreak have shown to belong to MLST sequence type 7 [7].
Strain P1/7 is MLST sequence type 1 and, as a single locus
variant, belongs to the same clonal complex as SC84. Previous
comparisons of strain P1/7 with S. suis strains 98HAH33 and
05ZYH33 showed that only 83.6% and 83.3% respectively of the
P1/7 CDSs had orthologous matches. It was also reported that
4.9% of the P1/7 genome was unique in comparison to S. suis
05ZYH33 and 98HAH33 [7]. However, according to our analysis,
all of the CDSs in the strain P1/7 genome have equivalent coding
regions in the S. suis 05ZYH33 and 98HAH33 sequences. The
difference in the number of orthologues identified can be
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Table 3. CDSs in the genome of S. suis strain P1/7 that have orthologues in S. pneumoniae and/or S. agalactiae, but not other
streptococci.
ID Product S. agalactiae S. pneumoniae
2603V/R A909 NEM316 TIGR4 D39 R6
SSU0003 diacylglycerol kinase protein + + + 2 2 2
SSU0103* replication initiation factor + + 2 2 2 2
SSU0104* conserved hypothetical protein + + 2 2 2 2
SSU0106* FtsK/SpoIIIE family protein + + 2 2 2 2
SSU0110 conserved hypothetical protein 2 2 + 2 2 2
SSU0173 putative membrane protein + + + 2 2 2
SSU0174 ABC transporter ATP-binding protein + + + 2 2 2
SSU0200 conserved hypothetical protein 2 2 2 + + +
SSU0226 putative transcriptional regulator 2 2 2 + + +
SSU0228 putative membrane protein 2 2 2 + + +
SSU0415 Fic protein family 2 2 2 + + +
SSU0417 conserved hypothetical protein 2 2 2 + + +
SSU0418 putative DNA-binding protein 2 2 2 + + +
SSU0423 hypothetical protein 2 + 2 2 2 2
SSU0424 putative signal peptidase I 2 2 + 2 2 2 2
SSU0428 sortase 2 + 2 2 2 2
SSU0440 acetyltransferase (GNAT) family protein 2 2 2 + + +
SSU0452* putative transposase (fragment) 2 2 2 + 2 2
SSU0520 putative rhamnosyl transferase 2 2 2 2 + 2
SSU0524 oligosaccharide repeat unit polymerase + 2 2 2 2 2
SSU0533 putative lipooligosaccharide sialyltransferase + + + 2 2 2
SSU0535 putative N-acetylneuraminic acid synthase + + + 2 2 2
SSU0537 putative transferase + + + 2 + +
SSU0538 N-acylneuraminate cytidylyltransferase + + + 2 2 2
SSU0541* putative transposase 2 2 2 2 + 2
SSU0544* putative transposase 2 2 2 + 2 +
SSU0549* putative transposase (fragment) 2 + 2 2 2 2
SSU0566* putative transposase 2 2 2 2 2 +
SSU0601 conserved hypothetical protein + + + 2 2 2
SSU0685 phosphomethylpyrimidine kinase + + + + + +
SSU0686 hydroxyethylthiazole kinase + + + + + +
SSU0687 thiamine-phosphate pyrophosphorylase + + + + + +
SSU0706 muramidase-released protein precursor 2 2 + 2 2 2
SSU0722 putative L-threonine aldolase + + + 2 2 2
SSU0829 plasmid addiction system, toxin protein 2 2 2 + + +
SSU0830 conserved hypothetical protein 2 2 2 + + +
SSU0879 zinc metalloproteinase 2 2 2 + + +
SSU0885 acetyltransferase (GNAT) family protein 2 2 2 2 + +
SSU1036* putative transposase + 2 2 2 2 2
SSU1050 hyaluronidase precursor (pseudogene) + + + + + +
SSU1054 putative membrane protein 2 2 2 + + +
SSU1067 conserved hypothetical protein + + + 2 2 2
SSU1074 putative membrane protein + 2 2 2 2 2
SSU1126 mannosyl-glycoprotein endo-beta-N-
acetylglucosaminidase (fragment)
+ 2 + 2 2 2
SSU1163 conserved hypothetical protein 2 2 2 + + +
SSU1201 putative surface-anchored protein 2 2 2 2 + +
SSU1242 VanZ like family protein 2 2 2 + + +
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accounted for by differences in gene prediction. The only large
scale region of difference is associated with the 89 kb putative PI
that is present in the two sequenced ST7 strains [7], and absent in
P1/7.
The genome of S. suis strain SC84 consists of a single circular
chromosome of 2,095,898 bp (accession number FM252031) and
containing 1,985 CDSs (Table 1), of which 87 are pseudogenes or
gene fragments (Table S1). Strain BM407 was isolated from a case
of human meningitis in Vietnam in 2004 and, like strain P1/7, has
MLST sequence type 1. The genome of S. suis strain BM407
consists of a single circular chromosome of 2,146,229 bp
(accession number FM252032) containing 2,040 CDSs (Table 1)
with 108 pseudogenes or gene fragments, and a plasmid (pBM407)
of 24,579 bp, (accession number FM252033) which contains 18
CDSs with 3 pseudogenes or gene fragments (Table S1).
Genome structure
The chromosomes of strains P1/7 and SC84 have a conserved
structure and are collinear along their length (Figure 4). The
BM407 chromosome is collinear, with the exception of a large
inversion (nucleotide 600371 to 1416050). The rearrangement is
due to recombination events between identical IS3 elements on
opposite replichores. Strains P1/7 and SC84 have asymmetric GC
skews (Figure 4), whereas BM407 does not. Whilst the asymmetric
conformation is present in two of the three strains sequenced, the
BM407 conformation is likely to be the more common form of the
S. suis chromosome as it maintains the replichore symmetry,
placing the origin and terminus of replication at opposite ends of
the circular chromosome, a common feature of bacterial circular
chromosomes [102]. Screening a collection of Vietnamese S. suis
ST1 strains [3] using PCR showed that the chromosome is found
in alternative orientations in closely related strains, suggesting that
the IS3-mediated recombination generating the chromosomal
rearrangement is an ongoing process (data not shown).
Comparison of the three S. suis genomes reveals discrete regions of
difference that distinguish these closely related strains. For strains P1/
7 and SC84, the regions of difference are exclusively associated with
MGEs; all of the genes identified in strain P1/7 outside MGEs have
orthologues in strain SC84. Strain BM407 also contains variation
associated with MGEs, but additionally there are two regions that
appear to be deleted, resulting in a reduction in the number of genes
on the chromosome of this strain in comparison to the other two. The
first is a small region of 268 bp, flanked by 30 bp direct repeats, that
encodes a putative membrane protein (in P1/7, SSU1245). The
second absent region is 3.3 kb and contains 2 complete CDSs
encoding subunits of an ATP-dependent exonuclease RexAB and the
ID Product S. agalactiae S. pneumoniae
2603V/R A909 NEM316 TIGR4 D39 R6
SSU1272 type I restriction-modification system S protein 2 2 2 + 2 2
SSU1273 type I restriction-modification system M protein 2 2 2 + + +
SSU1274 type I restriction-modification system R protein 2 2 2 + + +
SSU1383 putative acyl carrier protein phosphodiesterase + + + 2 2 2
SSU1402 putative membrane protein 2 + + + + +
SSU1403 PadR-like family regulator protein + + + + + +
SSU1405* putative transposase 2 2 2 + 2 2
SSU1422* putative transposase 2 2 2 + 2 2
SSU1546 putative membrane protein 2 2 2 + + +
SSU1631* putative transposase 2 2 + 2 2 2
SSU1718 putative membrane protein + + + 2 2 2
SSU1773 putative surface-anchored serine protease 2 2 2 + + +
SSU1795 toxin-antitoxin system, toxin protein + 2 2 + + +
SSU1796 toxin-antitoxin system, antitoxin protein + 2 2 + + +
SSU1852 putative amino-acid ABC transporter permease protein + + + 2 2 2
SSU1866 metal cation ABC transporter membrane protein + + + 2 2 2
SSU1872 CAAX amino terminal protease family protein + + + 2 2 2
SSU1881 sortase SrtD 2 2 2 + 2 2
SSU1882 sortase SrtC + + + + 2 2
SSU1883 sortase SrtB + 2 + + 2 2
SSU1885 putative surface-anchored protein + + + 2 2 2
SSU1886 putative surface-anchored protein (pseudogene) + + + + 2 2
SSU1901 putative nucleotidase 2 + 2 2 2 2
SSU1934 putative exported protein + + + 2 2 2
Orthologues identified using reciprocal Fasta, against the S. pneumoniae strains R6, TIGR4 and D39, and S. agalactiae strains NEM316, 2603V/R and A909. Orthologues
with matches to S. mutans UA159, S. gordonii Challis CH1, S. sanguinis SK36, S. pyogenes Manfredo, S. equi 4047, S. uberis 0140J, or S. thermophilus CNRZ1066 were not
included in the list. * contained on a putative MGE.
doi:10.1371/journal.pone.0006072.t003
Table 3. cont.
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C-terminal region of Mrp (SSUBM407_1126; equivalent to bases
733785 to 743796 in strain P1/7). Immediately downstream of mrp is
a partial IS1216 transposase. The 3-prime region of mrp
(pSSUBM407_006) is found on the plasmid pBM407, along with
rexAB (pSSUBM407_015 and pSSUBM407_016), the genes for the
missing chromosomal ATP-dependent exonuclease. The plasmid
also contains three copies of IS1216, and it is likely that the
chromosomal mrp and rexAB locus was deleted by IS1216-mediated
recombination.
Small-scale variation. The three strains also exhibited
small-scale variation at the nucleotide level including SNPs,
insertions and deletions. Of the three strains BM407 appears to be
the most diverse: comparison of strain BM407 to P1/7 identified
977 SNPs, 201 insertions, and 122 deletions in the core
chromosome (excluding ICE regions); and comparison to SC84
identified 1017 SNPs, 232 insertions, and 133 deletions, whereas a
comparison of strain P1/7 to SC84 identified 85 SNPs, 10
insertions, and 15 deletions.
The relative levels of variation are, on the face of it, at odds with
the relatedness of the strains as defined by MLST: P1/7 belongs to
the same sequence type as BM407, whereas SC84 is a single locus
variant of P1/7. MLST is based on variation at only seven loci in
the genome however, so it should not be surprising that it does not
necessarily reflect the overall diversity at the whole genome level.
Analysis of the distribution and density of SNPs in the genomes
suggest that recombination has generated allelic variation at
certain loci in the BM407 chromosome, thereby increasing the
apparent level of diversity. Eight loci in the BM407 chromosome
contained a high density of SNPs and were predicted by
Clonalframe to be regions that have undergone recombination
(Table 4). In total the SNPs in these regions account for ,60% of
the SNPs in the comparison with P1/7 and SC84.
Several of the putatively recombined loci in BM407 encode
functions or proteins that potentially have a role in virulence or
survival in the host. Two of the loci encode components of
transport systems, that include an ABC-type glycine betaine
Figure 4. Chromosomal comparisons of S. suis strains. Pairwise comparisons of the chromosomes of S. suis strains P1/7, SC84 and BM407
displayed using the Artemis Comparison Tool (ACT) [26]. The sequences have been aligned from the predicted replication origins (oriC; right). The
coloured bars separating sequences (red and blue) represent similarity matches identified by BLASTN analysis [15], with a score cut off of 100. Red
lines link matches in the same orientation; blue lines link matches in the reverse orientation. The green coloured boxes on the horizontal grey lines
mark up the extent of genomic islands identified on the chromosomes; pink boxes mark up the extent ICE regions.
doi:10.1371/journal.pone.0006072.g004
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transport system protein (SSUBM407_1490) homologous (56.1%
identity at the amino acid level) to a bile exclusion system protein
BilEB from Listeria monocytogenes shown to have a role in virulence
[103]; and a binding protein-dependent transport system
(SSUBM407_1447 to SSUBM407_1449) orthologous to a system
from S. mutans responsible for the uptake of melibiose, raffinose, and
isomaltotriose and the metabolism of melibiose, sucrose, and
isomaltosaccharides [104]. One of the loci is composed of three
CDSs that are part of the putative exopolysaccharide biosynthesis
cluster previously described. Two of the loci contain cell wall
anchored surface proteins, encoding a zinc carboxypeptidase
(SSUBM407_0646) and a N-acetylmuramoyl-L-alanine amidase
(SSUBM407_0662). A single regulatory CDS (SSUBM407_0840) is
found in the loci that appear to have undergone recombination.
This CDS encodes a sensor kinase which is part of a two component
regulatory system operon, with the SNPs being found in the N-
terminal region of the sensor kinase protein. SSUBM407_0840 is
homologous to ciaH of S. pneumoniae (49.3% identity at the amino
acid level) which plays a role in antibiotics resistance and
transformation competence [105]. Mutations within this regulatory
protein increase resistance to the cephalosporin cefotaxime.
There are fewer SNPs in the comparisons between P1/7 and
SC84 than were described in the publication by Chen et al. (2007)
which compared 98HAH33, 05ZYH33 and P1/7. Interestingly, a
comparison of SC84 with 05ZYH33, both strains from the same
outbreak, identified 2602 SNPs, 596 insertions, and 304 deletions.
This is in marked contrast to the low number of SNPs identified in
the comparison between P1/7 and SC84, two strains isolated from
different hosts, on different continents over 20 years apart.
Strains from the Sichuan outbreak have been found to be ST7
[8]. Examination of the sequence at MLST loci of 05ZYH33
revealed that they do not match the expected alleles for those of
ST7. In comparison to SC84, which itself belongs to ST7, SNPs
were identified at two of the seven MLST loci in the 05ZYH33
sequence: the aroA locus has 29 SNPs, and gki has 2 SNPs.
Although, it is possible that 05ZYH33 is actually a different
sequence type, albeit a double locus variant of ST7. The predicted
sequence type of 98HAH33 is more divergent still, being a triple
locus variant of ST7; the aroA has 6 SNPs, cpn has 1 single base
deletion, and dpr has 1 single base deletion. The most likely
explanation for these observations is that the sequence data for the
05ZYH33 and 98HAH33 strains is incorrect.
Table 4. Putative regions of recombination identified in the BM407 genome.
CDS Product Coordinates Number of SNPs
Region 1
SSUBM407_0131 acetate kinase 124591..125778 62
SSUBM407_0132 membrane protein 126092..126643 48
SSUBM407_0133 folypolyglutamate synthase 126699..127955 48
SSUBM407_0134 putative glutamyl-aminopeptidase 129061..128000 19
Region 2
SSUBM407_0646 putative surface-anchored zinc carboxypeptidase 715332..712147 33
SSUBM407_0647 putative cardiolipin synthetase 715548..717095 16
Region 3
SSUBM407_0662 N-acetylmuramoyl-L-alanine amidase 730766..733573 41
Region 4
SSUBM407_0668 polysaccharide export system ATP-binding protein 739785..740999 18
SSUBM407_0669 rhamnan synthesis protein F family protein 741020..742744 40
SSUBM407_0670 exopolysaccharide biosynthesis protein 742777..744036 16
Region 5
SSUBM407_0840 sensor histidine kinase 742777..744036 37
Region 6
SSUBM407_1445 glucan 1,6-alpha-glucosidase 1533333..1531717 16
SSUBM407_1446 sucrose phosphorylase 1534855..1533407 32
SSUBM407_1447 multiple sugar-binding transport system permease protein 1535755..1534925 33
SSUBM407_1448 multiple sugar-binding transport system permease protein 1536641..1535766 23
SSUBM407_1449 multiple sugar-binding protein precursor 1538008..1536773 16
Region 7
SSUBM407_1489 conserved hypothetical protein 1572295..1571534 31
SSUBM407_1490 ABC-type glycine betaine transport system protein 1573816..1572305 38
Region 8
SSUBM407_1989 acetyltransferase (GNAT) family protein 2097869..2097417 39
SSUBM407_1990 aldo/keto reductase family protein 2098790..2097879 14
SNP were identified in a comparison with the other ST 1 strain, P1/7.
doi:10.1371/journal.pone.0006072.t004
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Mobile genetic elements. Four regions of the P1/7 genome
were identified that had properties indicative of recent acquisition,
which include 1 prophage-like region and 3 miscellaneous islands,
which have been designated genomic islands. None of these
genomic islands carried characterized or putative virulence factors.
Equivalent genomic islands are present in the SC84 genome.
BM407 contains three of the genomic islands present in P1/7, but
is lacking genomic island 3 (in strain P1/7 nucleotides 835135 to
846313; Figure 4). In contrast to some streptococcal species such
as S. pyogenes [106], the proportion of the genome comprised by
MGEs is relatively small, at 1.8% of the P1/7 genome, suggesting
that the pan-genome of this species is smaller than other
streptococci [96,107], and that there may be some limitations or
restrictions to the amount of recent horizontal gene transfer in this
species.
Previous sequencing of the two S. suis strains associated with
meningitis outbreaks in China in 1998 and 2005 identified highly
similar 89 kb regions present in both genomes which were
designated a candidate PI [7]. This region is absent in strain
P1/7, but strain SC84 contains an almost identical region. This
island has a composite structure, contains several regions that
appear to be integrated MGEs and has a structure similar to
integrative conjugative elements (ICE) found in other streptococci
and other bacteria [108]. Accordingly this region has been
designated ICESsuSC84.
Integrative conjugative elements. ICE are commonly
found in streptococcal genomes. The most common are Tn916-
type elements, which almost invariably carry the tetracycline
resistance determinant tetM, often accompanied by other drug
resistance genes, and Tn5252-type elements, which are larger and
more variable in sequence. In many cases, Tn5252 transposons
are carrying Tn916 elements; varying arrangements of the two are
observed in different genomes, suggesting this association has
arisen independently on a number of occasions. Analogous with
the bacterial chromosome as a whole, the ICE have core and
accessory components to their gene complement. The conjugative
machinery appears to be relatively well conserved between the
ICE, with all of the streptococcal Tn5252-like elements sharing a
large recombination protein, as well as VirB4-type and VirD4-
type proteins. Furthermore, a genus-wide comparison of
streptococcal ICE reveals a surprising level of similarity in their
complement of cargo genes. The pezAT addiction toxin system,
first identified in the chromosome of S. pneumoniae, is found on
elements present in S. suis, S. pneumoniae and S. agalactiae,
presumably aiding fixation of the transposon following
integration. Bacteriocins, either alone or as part of a gene cluster
encoding the accompanying processing machinery, are present on
all the sequenced S. suis and S. pneumoniae [109] elements. Many of
the other cargo coding sequences appear to be involved in
increasing the stress tolerance of the host: abi genes are common,
and the ICE of S. dysgalactiae subsp. equisimilis and S. agalactiae
2603V/R encode multiple heavy metal resistance genes. Of greater
clinical importance, sequenced streptococcal ICE can carry genes
for resistance to tetracycline, erythromycin, chloramphenicol,
trimethoprim, aminoglycosides and streptomycin.
ICESsuSC84 is integrated into the SC84 S. suis genome in the 3-
prime region of the gene encoding the 50S ribosomal protein L7/
L12 (SSUSC84_0891). ICESsuSC84 has extended similarity to a
Tn2424 region (Figure 5) found in S. agalactiae strain NEM316 [94],
with three regions of difference. The first of these contains a putative
bacteriocin biosynthesis cluster that is disrupted by a putative
integron carrying five CDSs including an aminoglycoside resistance
gene (aminoglycoside 6-adenylyltansferase; SSUSC84_0863). The
second contains MGE-associated CDSs, including a Tn916
insertion that carries a tetracycline resistance gene (tetM;
SSUSC84_0827). The third region contains genes associated with
putative lantibiotic export/resistance and an asparagine synthetase.
The only component of the 89kb island that is an obvious candidate
Figure 5. Comparisons of the ICE regions from S. suis strains SC84 and S. agalactiae NEM315. The results of a TBLASTX comparison of the
ICESsuSC84 from strain SC84 and S. agalactiae NEM315 Tn2424 is displayed using the Artemis Comparison Tool (ACT) [26].
doi:10.1371/journal.pone.0006072.g005
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for a pathogenicity determinant is a surface-anchored protein that
contains a LPXTGmotif that is annotated as an agglutinin receptor
(SSUSC84_0873). This protein is found in the S. agalactiae element
(and other streptococci) and contains a glucan-binding domain.
The BM407 genome contains two regions with extended
similarity to ICESsuSC84. The first of these, ICESsuBM4071, is
inserted into a luciferase-like monooxygenase (SSUBM407_0455),
resulting in the disruption of this CDS. The second, ICES-
suBM4072, is found at the same locus as ICESsuSC84; the element is
inserted into the 3-prime region of the gene encoding the 50S
ribosomal protein L7/L12 (SSUBM407_0933). Although ICES-
suBM4072 and ICESsuSC84 are inserted at the same attachment site
it is likely that they have arisen in these two strains by independent
insertion events. Not only do the two elements contain regions of
difference, the conserved DNA in the ICEs is more diverse than
the core chromosome DNA (the ICEs exhibit ,95298% identity,
in contrast to ,992100% identity for chromosomal DNA).
ICESsuBM4072 and ICESsuSC84 have conserved tyrosine family site-
specific integrases (SSUBM407_1003 and SSUSC84_0807;
Figure 6), which is probably the explanation for why these
elements integrated at the same site in the respective chromo-
somes, whereas ICESsuBM4071 contains a serine family recombi-
nase (SSUBM407_0524) that directs the insertion of this element
elsewhere on the BM407 chromosome.
Comparison of the BM407 and SC84 ICEs shows that CDSs
associated with conjugation are conserved (Figure 6). The ICEs
contain regions of sequence divergence with ICESsuBM4071
appearing to be most diverse, containing a greater proportion of
unique sequence, and an inverted region. All three elements
contain variants of Tn916; ICESsuBM4071 and ICESsuSC84 have
Tn916 with the same gene content, whilst ICESsuBM4072 contains
additional genes encoding the tetracycline resistance protein TetL
(SSUBM407_0984) and chloramphenicol acetyltransferase
(SSUBM407_0980). In addition to the drug resistance genes
associated with Tn916, ICESsuBM4072 also carries genes encoding
the tetracycline resistance protein TetO (SSUBM407_0954),
erythromycin ribosome methylase ErmB (SSUBM407_0952) and
dihydrofolate reductase (SSUBM407_0957), in a region of
difference located elsewhere on the element.
Unlike ICESsuBM4072, ICESsuBM4071 does not carry as many
CDSs associated with drug resistance. Amongst its cargo are a lactose
utilization operon (SSUBM407_0510 to SSUBM407_0519), includ-
ing a glucokinase-like protein, a galactose-6-phosphate isomerase, a
tagatose-6-phosphate kinase, a tagatose 1,6-diphosphate aldolase, a 6-
phospho-beta-galactosidase, and a PTS system lactose-specific
transporter, which are absent in ICESsuBM4072 and ICESsuSC84.
The chromosome of BM407 (and P1/7 and SC84) already contains
homologues of these CDSs at two loci (SSUBM407_0879 to
SSUBM407_0889 and SSUBM407_1060). Interestingly the chro-
mosomal copy of the tagatose-6-phosphate kinase lacC
(SSUBM407_0883) is mutated in BM407, therefore the provision
of an additional copy of this CDS on ICESsuSC84 complements the
mutation. Complete lactose utilization operons have been found on
other ICEs, including the S. agalactiae NEM315 ICE.
Figure 6. Comparisons of the ICE regions from S. suis strains BM407 and SC84. The results of a TBLASTX comparison of the ICESsuBM4071
and ICESsuBM4072 regions from strain BM407, and ICESsuSC84 from strain SC84 is displayed using the Artemis Comparison Tool (ACT) [26].
doi:10.1371/journal.pone.0006072.g006
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Contained on ICESsuSC84 is a two component regulator, salK/
salR (SSUSC84_0849 and SSUSC84_0850), that has been
implicated in the virulence of the Chinese isolates in an animal
model [110]. These regulatory components are part of a larger
operon encoding lantibiotic biosynthesis, similar to the salivaricin
cluster of Streptococcus salivarius [111]. Neither of the ICEs in
BM407 contains this cluster (Figure 6); these elements contain
alternative cargo CDSs in equivalent regions on these elements.
Upstream of the operon is a CDS encoding a lantibiotic precursor
(SSUSC84_0866). In SC84, and also in 05ZYH33 and 98HAH33,
the operon has been disrupted by the insertion of a 7.9 kb element
containing 9 CDSs, one of which encodes an aminoglycoside 6-
adenylyltransferase (SSUSC84_0863), into the homologue of the
S. salivarius salivaricin C biosynthesis gene salM (SSUSC84_0856).
The precise regulatory function of SalK/SalR remains unclear,
but their operonic association with the lantibiotic cluster suggests
that their primary role is associated with this function. However it
is possible that regulatory components of this operon may have
been adapted to other functions. S. pyogenes with a mutation in salY,
a gene encoding a putative ABC transporter permease of a
lantibiotic operon, was attenuated for virulence in a zebrafish
invasive-disease model [112]. Analysis of the S. pyogenes lantibiotic
cluster showed that it contained a homologue of salM that was
mutated, suggesting that like the lantibiotic cluster in S. suis SC84,
this cluster also no longer produced a functional lantibiotic, but it
was still was essential for full virulence.
Screening of 91 Vietnamese S. suis serotype 2 strains of MLST
ST1 isolated from patients with meningitis, for the presence of
ICESsuSC84 using PCR targeted at the insertion sites [7], indicated
that this ICE is not absolutely required for virulence in humans as
16 (17.6%) strains lacked the element (manuscript in preparation).
In addition, only 41 (45%) carried sequences homologous to the
salK/salR genes, suggesting that the presence of these genes cannot
be used as a marker of virulence. Similar to strains BM407 and
SC84, all strains containing ICE-associated sequences were
resistant to tetracycline whereas those that were negative in the
screening were sensitive, indicating the common presence of ICE
carrying tet genes in these isolates.
Discussion
The sequencing and detailed annotation of the S. suis P1/7,
SC84 and BM407 genomes provides valuable data for studying
the evolutionary events that are shaping the virulence and drug
resistance in this emerging zoonotic pathogen.
There is strong evidence that genetic background influences the
ability of S. suis to cause zoonotic infections as human disease
isolates are almost always serotype 2 and are very closely related
by MLST. Of the 121 STs in the S. suis MLST data base (http://
ssuis.mlst.net/), only five STs have representative isolated from
humans, and four (ST1, ST6, ST7 and ST84) out of the five are all
part of the same clonal complex. Two of the strains in this study
(P1/7 and BM407) introduce a greater degree of diversity into the
comparisons, insofar as that they are from different geographical
areas, and belong to different STs.
A major feature of the previously sequenced S. suis strains’
genomes hypothesised to be important for pathogenicity, is an
89 kb ICE region designated as a candidate PI [7]. BM407 also
contains an almost identical ICE with some notable differences
that encompass drug resistance genes, and a two-component
regulatory system associated with a bacteriocin cluster. Sequence
variation in the BM407 ICE suggest that although it is present at
an orthologous site, it has been independently acquired.
The comparative analysis suggests that ICEs have been the
major contributor to the evolution of drug resistance in the strains
of S. suis examined. Although it is not possible to pinpoint the
origins of the S. suis ICEs, due to the limited number of these
elements in the databases, it is apparent from the analyses that
they are closely related to ICEs found in phylogenetically distant
streptococci. It is worth noting that some of these species occupy
the same niches as S. suis, suggesting that inter-species genetic
exchange is taking place. This has implications for defining the
pan-genomes of some streptococcal species, since it may not be
possible to define their boundaries if the pool of MGEs they
exchange is effectively communal.
Aside from the ICEs, the virulence determinant inventories of
P1/7, SC84 and BM407 strains are identical. Small nucleotide
differences resulting from point mutation and recombination were
observed in the genome comparisons. This variation may have
subtle effects on the expression and function of these genes, and as a
corollary, generate differences in the virulence phenotypes. To this
extent it is possible that some of the small nucleotide differences
observed in the SC84 and BM407 genomes in comparison to P1/7
may influence the ability of these strains to cause disease. However,
as the capacity of P1/7 to cause human disease is unknown, it is not
possible to speculate on the impact of genomic differences identified
in this study on host-association. Future studies intending to increase
the depth of sequencing in this zoonotic lineage will help unravel the
pathogenic significance of sequence variation.
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